Healthcare Biotechnology: A Practical Guide | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
A01=Dimitris Dogramatzis
Age Group_Uncategorized
Age Group_Uncategorized
Author_Dimitris Dogramatzis
automatic-update
Category1=Non-Fiction
Category=KC
Category=KJVN
Category=MBP
Category=PS
Category=TCB
Category=TDCW
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Healthcare Biotechnology: A Practical Guide

English

By (author): Dimitris Dogramatzis

Foreseeing and planning for all of the possibilities and pitfalls involved in bringing a biotechnology innovation from inception to widespread therapeutic use takes strong managerial skills and a solid grounding in biopharmaceutical research and development procedures. Unfortunately there has been a dearth of resources for this aspect of the field. Until now.

Focusing on the management of healthcare-related biotech, from conception through the products regulatory approval and entire life cycle, Healthcare Biotechnology: A Practical Guide provides a practical, applicable resource to assist all health-care related biotech professionals in their day-to-day activities from the lab to the boardroom.

Divided into six sections, the book begins with current systems and recent progress and controversy, major players and products, and a comparison with the pharmaceutical industry. It covers intellectual property protection and management, the innovation cycle, patent application, commercialization, and competition.

Coverage includes funding, partnering, cash-intensive activities, financing alternatives, and the complexities of alliance implementation and management. It highlights research, development, and biomanufacturing; and examines clinical trial design and regulations; fast-track approvals; and patient recruitment as well as production platforms and processes, costs, strategies, and timelines.

It investigates marketing including planning, promotion, pricing, supply chain management, and bio-brand lifecycle management. It concludes with tips on running the business, offering diverse biobusiness models and reasonable expectations from inception through maturity and decline.

An indispensible guide, this book offers more than 40 figures, 220 tables, and 180 references as well as a list of abbreviations and a business plan outline. Each chapter contains 10 questions to reinforce the material covered and 10 exercises

See more
Current price €147.59
Original price €163.99
Save 10%
A01=Dimitris DogramatzisAge Group_UncategorizedAuthor_Dimitris Dogramatzisautomatic-updateCategory1=Non-FictionCategory=KCCategory=KJVNCategory=MBPCategory=PSCategory=TCBCategory=TDCWCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 1111g
  • Dimensions: 156 x 234mm
  • Publication Date: 14 Dec 2010
  • Publisher: Taylor & Francis Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781439847466

About Dimitris Dogramatzis

Dr. Dimitris Dogramatzis was born in Greece in 1962. After earning a Bachelor's diploma in Pharmacy from the University of Patras in Greece he spent the next seven years in Texas studying and working for the University of Texas system. During this period he completed his Ph.D. in Pharmacology and Toxicology at the University of Texas Medical Branch at Galveston. Later he went on to complete two successive postdoctoral trainings at the University of Texas Medical Branch at Galveston as well as at the M.D. Anderson Cancer Center at Houston Texas. He is currently the owner of a retail pharmacy in Athens a business consultant and a writer.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept